CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

Data Compilation
#PharmaFlow

Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

Stock Recap
#PipelineProspector

Betamethasone Dipropionate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

59 API Suppliers, 16 USDMF, 8 CEP/COS, 6 JDMF, 9 EU WC, 2 KDMF, 12 NDC API, 38 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

289 FDF Dossiers, 79 FDA Orange Book, 152 Europe, 3 Canada, 24 Australia, 9 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE, CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - EQ 0.05% BASE, OINTMENT;TOPICAL - EQ 0.05% BASE, CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 3 DKSH, 1 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 1 Actylis, 11 BASF, 1 Clariant, 4 Corel Pharma Chem, 2 Finar, 4 Lubrizol Life Science Health, 11 Roquette, 1 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

26 Topical, 13 Film Formers & Plasticizers, 9 Parenteral, 8 Emulsifying Agents, 7 Thickeners and Stabilizers, 7 Solubilizers, 5 Fillers, Diluents & Binders, 5 Lubricants & Glidants, 4 Coating Systems & Additives, 4 Taste Masking, 3 Direct Compression, 3 Surfactant & Foaming Agents, 2 Chewable & Orodispersible Aids, 2 Granulation, 2 Controlled & Modified Release, 1 Soft Gelatin, 1 Rheology Modifiers, 1 Co-Processed Excipients

DIGITAL CONTENT

48 News #PharmaBuzz

48 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions, 17 Regulatory FDF Prices, 16 Annual Reports

MARKET PLACE

23 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
31/10/2025	Symbiotec Pharmalab	India	SYMBIOTEC PHARMALAB PRIVATE LIMITED Indore IN	R1-CEP 2012-079 - Rev 00	Betamethasone dipropionate, Micronised	2018-02-19	Valid	Chemical		809
31/10/2025	Axplora	Germany	FARMABIOS S.p.A Gropello Cairoli IT	R1-CEP 2003-232 - Rev 03	Betamethasone dipropionate, Micronised	2023-02-08	Valid	Chemical		809

Betamethasone Dipropionate

Betamethasone Dipropionate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

59 API Suppliers

16 USDMF

8 CEP/COS

6 JDMF

9 EU WC

2 KDMF

12 NDC API

38 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

289 FDF Dossiers

79 FDA Orange Book

152 Europe

3 Canada

24 Australia

9 South Africa

22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE

CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - EQ 0.05% BASE

OINTMENT;TOPICAL - EQ 0.05% BASE

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

2 SPI Pharma

3 DKSH

1 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

3 Kirsch Pharma

1 Actylis

11 BASF

1 Clariant

4 Corel Pharma Chem

2 Finar

4 Lubrizol Life Science Health

11 Roquette

1 Seppic

2 Shandong Focus Biotechnology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

26 Topical

13 Film Formers & Plasticizers

9 Parenteral

8 Emulsifying Agents

7 Thickeners and Stabilizers

7 Solubilizers

5 Fillers, Diluents & Binders

5 Lubricants & Glidants

4 Coating Systems & Additives

4 Taste Masking

3 Direct Compression

3 Surfactant & Foaming Agents

2 Chewable & Orodispersible Aids

2 Granulation

2 Controlled & Modified Release

1 Soft Gelatin

1 Rheology Modifiers

1 Co-Processed Excipients

DIGITAL CONTENT

48 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions

17 Regulatory FDF Prices

16 Annual Reports

MARKET PLACE

CREAM;TOPICAL - EQ 0.05% BASE;1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons